Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney (
1). This tumor originates from the epithelial cells of the renal tubules and is located mainly in the cortical region of the kidney (
2). According to GLOBOCAN 2018 statistics, about 403 000 cases of renal neoplasm are diagnosed in the world annually, of which approximately 25 4500 cases were registered in men compared to 148 0000 in women, and 175 000 resulted fatality from the disease, of which approximately 114 000 were men and 61 000 were women (
1). RCC accounts for about 90% of all malignant kidney tumors and 2% of all cancers in adults (
3). Risk factors include aging, sex, smoking, high blood pressure, obesity, chronic hemodialysis, genetic factors, and those who are more functionally in contact with cadmium and asbestos (
4). These malignant kidney tumors were more prevalent in the 60s and 70s, and men are affected twice as women (
5). The most common histological subtypes of RCC are clear cell renal cell carcinoma (ccRCC), papillary renal cell carcinoma (PRCC), and chromophobe renal cell carcinoma (ChRCC). Among the histological subtypes of renal cell carcinoma, ccRCC is the most common type and makes 75% of cases (
6). Grossly ccRCC is generally large, spherical in shape, and has a cross-sectional area of golden yellow or orange or even gray to white, which has cystic and hemorrhagic areas and microscopically the cells show clear or granular cytoplasm due to the presence of fat and glycogen (
2). PRCC makes up 10% to 15% of the histological subtype of RCC; as its name suggests, the development of cancer cells is papillary. According to Gross, these tumors have cystic nature and yellow necrotic tissue areas (
7). ChRCC makes 5% of the histological subtype of RCC that has cells with sharply defined plant-like cell bonders, raisinoid nuclei, and perinuclear halos (
8).